Release Date: 14/04/14 09:00 Summary: Quarterly Cashflow Report Price Sensitive: No Download Document 97.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%